Cannabidiol and Cannabigerol Modulate Cariogenic Virulence in Cross-Kingdom Biofilms In Vitro

Introduction and aims The nonpsychoactive phytocannabinoids cannabidiol (CBD) and cannabigerol (CBG) have been increasingly recognized for their antimicrobial properties. However, their effect on Streptococcus mutans – Candida albicans dual-species biofilms, which exhibit enhanced cariogenicity, remains unclear. This study aimed to determine whether CBD and CBG suppress cariogenic traits in S. mutans–C. albicans biofilms and to identify CBD-responsive molecular pathways associated with biofilm virulence. Methods Planktonic assays and in vitro dual-species biofilm models of S. mutans and C. albicans were established. The effects of CBD and CBG on microbial viability, biofilm inhibition, mature biofilm disruption, acid production, and extracellular polysaccharide (EPS) production were assessed. CBD-associated transcriptional responses were analysed by RNA-seq and validated by qRT-PCR. Results Both CBD and CBG significantly inhibited S. mutans growth (minimum inhibitory concentrations, 2.5-5 µg/mL), suppressed dual-species biofilm formation, disrupted mature biofilms, and reduced acidogenesis and EPS production. In CBD-treated biofilms, transcriptomic analysis showed altered expression of S. mutans genes involved in membrane and envelope homeostasis, quorum-sensing-like competence, mutacin production, and metabolic pathways. While CBD had a limited impact on C. albicans viability in dual-species biofilms, it significantly altered the expression of virulence-related genes involved in central carbon metabolism, mannan biosynthesis, and stress responses. Conclusions CBD and CBG modulated the cariogenic traits in S. mutans – C. albicans dual-species biofilms, while CBD induced transcriptomic changes in pathways associated with biofilm fitness and virulence. These findings support further evaluation of phytocannabinoids as modulators of polymicrobial dental biofilm phenotypes and warrant further in vivo validation. Clinical relevance This study identifies nonpsychoactive phytocannabinoid-responsive phenotypes in cross-kingdom cariogenic biofilms and highlights their potential to modulate biofilm virulence. These findings provide a framework for further research into phytocannabinoids as oral biofilm modulators.

Authors

Institutions

Publication Details

Journal
International Dental Journal
Published
2026-09-19
DOI
https://doi.org/10.1016/j.identj.2026.111173
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Cannabidiol and Cannabigerol Modulate Cariogenic Virulence in Cross-Kingdom Biofilms In Vitro

David Bovard, Jianhang Bao, Yuankun Zhai, Xinyan Huang et al.
International Dental Journal
Cannabis and Cannabinoid Research
article

Cannabidiol and Cannabigerol Modulate Cariogenic Virulence in Cross-Kingdom Biofilms In Vitro

David Bovard, Jianhang Bao, Yuankun Zhai, Xinyan Huang, Jiaqi Zhu, Shuangyue Wu, Yanfang Ren, Wenhao Xia
article en

Abstract

Introduction and aims The nonpsychoactive phytocannabinoids cannabidiol (CBD) and cannabigerol (CBG) have been increasingly recognized for their antimicrobial properties. However, their effect on Streptococcus mutans – Candida albicans dual-species biofilms, which exhibit enhanced cariogenicity, remains unclear. This study aimed to determine whether CBD and CBG suppress cariogenic traits in S. mutans–C. albicans biofilms and to identify CBD-responsive molecular pathways associated with biofilm virulence. Methods Planktonic assays and in vitro dual-species biofilm models of S. mutans and C. albicans were established. The effects of CBD and CBG on microbial viability, biofilm inhibition, mature biofilm disruption, acid production, and extracellular polysaccharide (EPS) production were assessed. CBD-associated transcriptional responses were analysed by RNA-seq and validated by qRT-PCR. Results Both CBD and CBG significantly inhibited S. mutans growth (minimum inhibitory concentrations, 2.5-5 µg/mL), suppressed dual-species biofilm formation, disrupted mature biofilms, and reduced acidogenesis and EPS production. In CBD-treated biofilms, transcriptomic analysis showed altered expression of S. mutans genes involved in membrane and envelope homeostasis, quorum-sensing-like competence, mutacin production, and metabolic pathways. While CBD had a limited impact on C. albicans viability in dual-species biofilms, it significantly altered the expression of virulence-related genes involved in central carbon metabolism, mannan biosynthesis, and stress responses. Conclusions CBD and CBG modulated the cariogenic traits in S. mutans – C. albicans dual-species biofilms, while CBD induced transcriptomic changes in pathways associated with biofilm fitness and virulence. These findings support further evaluation of phytocannabinoids as modulators of polymicrobial dental biofilm phenotypes and warrant further in vivo validation. Clinical relevance This study identifies nonpsychoactive phytocannabinoid-responsive phenotypes in cross-kingdom cariogenic biofilms and highlights their potential to modulate biofilm virulence. These findings provide a framework for further research into phytocannabinoids as oral biofilm modulators.

International Dental JournalVol. 76(6)
Henan University (CN), DSO National Laboratories (SG), University of Rochester Medical Center (US), Kaifeng University (CN), Eastman Chemical Company (United States) (US)
Life below water
Openalex Percentile: Top 12%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.